Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs
US10544402B2 · kind B2 · utility
1Cited by
6References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 15, 2017 |
| Grant date | Jan 28, 2020 |
| Priority date | — |
| Expiry date | Jul 1, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02P20/52
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present disclosure provides engineered transaminase polypeptides for the production of amines, polynucleotides encoding the engineered transaminases, host cells capable of expressing the engineered transaminases, and methods of using the engineered transaminases to prepare compounds useful in the production of active pharmaceutical agents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.